Tourmaline Bio Inc
NASDAQ:TRML
Cash Flow Statement
Cash Flow Statement
Tourmaline Bio Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(23)
|
(27)
|
(34)
|
(40)
|
(48)
|
(57)
|
(64)
|
(70)
|
(74)
|
(78)
|
(75)
|
(63)
|
(42)
|
(33)
|
(36)
|
(49)
|
(73)
|
(83)
|
(88)
|
|
| Depreciation & Amortization |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
2
|
3
|
4
|
4
|
6
|
7
|
9
|
0
|
(2)
|
(4)
|
(6)
|
6
|
7
|
8
|
9
|
7
|
7
|
8
|
|
| Other Non-Cash Items |
1
|
3
|
4
|
5
|
5
|
6
|
7
|
9
|
11
|
13
|
11
|
9
|
14
|
9
|
8
|
7
|
(1)
|
(0)
|
1
|
|
| Change in Working Capital |
2
|
1
|
(1)
|
(1)
|
2
|
3
|
2
|
2
|
1
|
2
|
3
|
0
|
(0)
|
(2)
|
(1)
|
(3)
|
(3)
|
(1)
|
1
|
|
| Cash from Operating Activities |
(19)
N/A
|
(23)
-20%
|
(31)
-32%
|
(36)
-17%
|
(40)
-12%
|
(47)
-18%
|
(54)
-13%
|
(57)
-6%
|
(61)
-7%
|
(61)
-1%
|
(59)
+4%
|
(53)
+10%
|
(28)
+47%
|
(26)
+7%
|
(30)
-13%
|
(45)
-52%
|
(77)
-71%
|
(84)
-9%
|
(86)
-2%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(132)
|
(111)
|
(215)
|
(200)
|
(94)
|
(74)
|
47
|
51
|
59
|
65
|
53
|
102
|
4
|
(213)
|
(232)
|
(300)
|
(194)
|
21
|
47
|
|
| Cash from Investing Activities |
(133)
N/A
|
(113)
+16%
|
(216)
-92%
|
(201)
+7%
|
(96)
+52%
|
(77)
+20%
|
43
N/A
|
47
+11%
|
56
+17%
|
63
+13%
|
52
-18%
|
101
+96%
|
4
-96%
|
(212)
N/A
|
(231)
-9%
|
(299)
-29%
|
(194)
+35%
|
21
N/A
|
47
+125%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
131
|
131
|
269
|
137
|
138
|
138
|
(0)
|
1
|
0
|
0
|
0
|
0
|
92
|
0
|
92
|
92
|
0
|
1
|
1
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
65
|
226
|
226
|
226
|
161
|
(0)
|
0
|
|
| Cash from Financing Activities |
131
N/A
|
131
+0%
|
269
+105%
|
136
-49%
|
137
+1%
|
137
+0%
|
(0)
N/A
|
1
N/A
|
0
-59%
|
0
+8%
|
0
+19%
|
0
+3%
|
157
+48 963%
|
318
+103%
|
318
0%
|
317
0%
|
161
-49%
|
0
-100%
|
1
+198%
|
|
| Change in Cash | ||||||||||||||||||||
| Net Change in Cash |
(21)
N/A
|
(4)
+79%
|
22
N/A
|
(101)
N/A
|
1
N/A
|
13
+1 165%
|
(11)
N/A
|
(9)
+18%
|
(5)
+44%
|
1
N/A
|
(7)
N/A
|
49
N/A
|
133
+173%
|
79
-40%
|
57
-29%
|
(27)
N/A
|
(110)
-308%
|
(63)
+43%
|
(38)
+39%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(21)
N/A
|
(24)
-18%
|
(32)
-31%
|
(37)
-18%
|
(42)
-14%
|
(51)
-20%
|
(58)
-14%
|
(61)
-5%
|
(64)
-5%
|
(64)
+1%
|
(60)
+5%
|
(54)
+10%
|
(28)
+48%
|
(26)
+8%
|
(29)
-12%
|
(44)
-53%
|
(77)
-73%
|
(84)
-9%
|
(86)
-2%
|
|